Publication | Open Access
Phase II study of osimertinib in NSCLC patients with EGFR exon 20 insertion mutation: A multicenter trial of the Korean Cancer Study Group (LU17-19)
33
Citations
0
References
2019
Year
Neuro-oncologyOncologyPathologyPhase Ii StudyCancer TreatmentCancer GeneticsNsclc PatientsMedicineRadiation OncologyMolecular OncologyInsertion Mutation
No additional data available for this publication yet. Check back later!